Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2009 3
2010 2
2011 1
2012 4
2013 5
2014 3
2015 7
2016 3
2017 5
2018 4
2019 12
2020 12
2021 18
2022 13
2023 11
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

89 results

Results by year

Filters applied: . Clear all
Page 1
Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study.
Peyrin-Biroulet L, Allegretti JR, Rubin DT, Bressler B, Germinaro M, Huang KG, Shipitofsky N, Zhang H, Wilson R, Han C, Feagan BG, Sandborn WJ, Panés J, Hisamatsu T, Lichtenstein GR, Sands BE, Dignass A; QUASAR Study Group. Peyrin-Biroulet L, et al. Gastroenterology. 2023 Dec;165(6):1443-1457. doi: 10.1053/j.gastro.2023.08.038. Epub 2023 Sep 1. Gastroenterology. 2023. PMID: 37659673 Free article. Clinical Trial.
Adrenomedullin for biologic-resistant Crohn's disease: A randomized, double-blind, placebo-controlled phase 2a clinical trial.
Kita T, Ashizuka S, Takeda T, Matsumoto T, Ohmiya N, Nakase H, Motoya S, Ohi H, Mitsuyama K, Hisamatsu T, Kanmura S, Kato N, Ishihara S, Nakamura M, Moriyama T, Saruta M, Nozaki R, Yamamoto S, Inatsu H, Watanabe K, Kitamura K. Kita T, et al. Among authors: kanmura s. J Gastroenterol Hepatol. 2022 Nov;37(11):2051-2059. doi: 10.1111/jgh.15945. Epub 2022 Jul 25. J Gastroenterol Hepatol. 2022. PMID: 35840351 Free PMC article. Clinical Trial.
Huge gastric lesion disappears in a day.
Tanaka A, Kanmura S, Sakiyama T, Ido A. Tanaka A, et al. Among authors: kanmura s. Dig Liver Dis. 2021 Oct;53(10):1359. doi: 10.1016/j.dld.2020.08.006. Epub 2020 Aug 24. Dig Liver Dis. 2021. PMID: 32855087 No abstract available.
A case of autoimmune hepatitis with thymoma and myasthenia gravis.
Sakae H, Mawatari S, Oda K, Tabu K, Kumagai K, Mizuno K, Nozuma S, Kitazono I, Kanmura S, Ido A. Sakae H, et al. Among authors: kanmura s. Clin J Gastroenterol. 2022 Aug;15(4):765-770. doi: 10.1007/s12328-022-01641-5. Epub 2022 Jun 27. Clin J Gastroenterol. 2022. PMID: 35761020
Features of patients who developed hepatocellular carcinoma after direct-acting antiviral treatment for hepatitis C Virus.
Mawatari S, Kumagai K, Oda K, Tabu K, Ijuin S, Fujisaki K, Tashima S, Inada Y, Uto H, Saisyoji A, Hiramine Y, Hashiguchi M, Tamai T, Hori T, Taniyama O, Toyodome A, Sakae H, Kure T, Sakurai K, Moriuchi A, Kanmura S, Ido A. Mawatari S, et al. Among authors: kanmura s. PLoS One. 2022 Jan 12;17(1):e0262267. doi: 10.1371/journal.pone.0262267. eCollection 2022. PLoS One. 2022. PMID: 35020772 Free PMC article.
Clinical Effect of Lenvatinib Re-Administration after Transcatheter Arterial Chemoembolization in Patients with Intermediate Stage Hepatocellular Carcinoma.
Mawatari S, Tamai T, Kumagai K, Saisyoji A, Muromachi K, Toyodome A, Taniyama O, Sakae H, Ijuin S, Tabu K, Oda K, Hiramine Y, Moriuchi A, Sakurai K, Kanmura S, Ido A. Mawatari S, et al. Among authors: kanmura s. Cancers (Basel). 2022 Dec 13;14(24):6139. doi: 10.3390/cancers14246139. Cancers (Basel). 2022. PMID: 36551623 Free PMC article.
89 results